News
DexCom (NasdaqGS:DXCM) recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose ...
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target of $107.00. The company’s shares closed la ...
Abbott's growth potential with GLP-1 tailwinds, robust FCF, and dividend growth. Read more on how ABT navigates tariffs while ...
We've spotted 1 possible red flag for DexCom you should be aware of. NasdaqGS:DXCM Earnings Per Share Growth as at Apr 2025 Uncover the next big thing with financially sound penny stocks that ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom ( DXCM – Research Report) yesterday and set a price target of $98.00. The company’s shares closed yesterday at $67.39. Filter, ...
Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for potential breaches of ...
RBC Capital lowered the firm’s price target on DexCom (DXCM) to $100 from $115 and keeps an Outperform rating on the shares as part of a ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $98.00. The company’s shares closed yesterday at $67.39.
DexCom Inc. closed 51.60% short of its 52-week high of $139.24, which the company achieved on April 25th.
5d
Zacks.com on MSNTap Into the Silver Economy Boom With These Aging Demographics StocksThe global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices ...
Trump Media and Technology Group (DJT) has tied up with asset manager Yorkville America Equities and Index Technologies Group to launch Truth Social-branded Separately Managed Accounts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results